Continuous temperature monitoring for cytokine release syndrome
Part of Blood & lymphatic, Cancer, Heart & circulation, Immune system & allergy clinical trials.
This study tests a wearable device that continuously monitors your body temperature to detect cytokine release syndrome, a possible side effect of certain immunotherapies. The goal is to catch it early so you can get treatment faster.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are enrolled in an active cancer treatment trial at NIH that uses a type of immunotherapy (like CAR T-cells or bispecific antibodies) that can cause cytokine release syndrome (a severe immune reaction).
- You have received your immunotherapy dose and are admitted to the NIH Clinical Center.
- You can understand and sign the consent form.
- You do not have a history of solid organ or stem cell transplant requiring ongoing immune-suppressing medicine.
- You do not have a current active infection or condition causing repeated fevers.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a remote patient monitoring program for people with cancer who are starting treatment. It aims to see if monitoring from home can improve care and support.
This study follows patients with relapsed or hard-to-treat B-cell lymphoma who are receiving CD19-directed CAR T cell therapy. Researchers collect blood and tissue samples to better understand each patient's unique risk profile, aiming to improve how the treatment is monitored and managed.
This trial tests a wearable device that continuously measures your body temperature while you are in the hospital. It may help doctors track fever or temperature changes caused by infections or other illnesses.
This trial tests a smartphone app and wearable sensor to track your temperature after leaving the hospital, alerting you or your doctors if a fever develops. It aims to catch fevers early so you can get faster care.
This study tests a small wearable sensor that continuously tracks body temperature in children receiving cancer treatment. It may help detect fevers early, which is important because fevers can be a sign of serious infection during chemotherapy.
This study tests a new arm-worn sensor called Thermodiag that measures body temperature continuously. It aims to see how accurate and safe it is for patients in intensive care, potentially replacing frequent manual temperature checks.
Hear when a new Cytokine Release Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.